Clinical Trials in Lithuania — Country Dashboard | 245 EU Studies

Filter these 245 trials by condition, phase, sponsor and more.

245 Registered trials

79 Recruiting

153 Completed trials

129 Sponsors active

76 Research sites

Phase III

Phase II

Phase III: 168 Phase II/III: 15 Phase II: 45 Phase I/II: 2 Phase IV: 5 Phase I: 3 Phase I (Other): 2 Phase I (FiH): 2 Other: 3

Oversight events in trials active here:

28 serious breaches 105 temporary halts 6 urgent safety measures 17 unexpected events 12 corrective measures across 45 trials

Top conditions

245 total

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Phase III Adults at high risk of cardiovascular events without prior M… Amgen Inc.
First line treatment with osimertinib in non-small cell lung cancer, coupled with studies on biological samples. Ended

2024-513881-20-00 Phase II EGFR-mutated non-small cell lung cancer Vestre Viken HF
Perioperative treatment of locally advanced resectable gastric or GEJ adenocarcinoma Ended

2023-509595-42-00 Phase III Gastric and gastroesophageal junction (GEJ) adenocarcinoma Merck Sharp & Dohme LLC
EQU-001 as an Add-On Drug for People with Focal Seizures while on Medication Ended

2022-500302-18-00 Phase II Epilepsy Equilibre Biopharmaceuticals B.V.
A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended

2022-501353-37-00 Phase III Reversal of anticoagulation effect in patients on a FXa inhi… Astrazeneca AB

Showing 241–245 of 245 trials